Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-4101
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities ; volume:11 ; number:1 ; day:27 ; month:2 ; year:2020 ; pages:1-6 ; date:12.2020
Insights into imaging ; 11, Heft 1 (27.2.2020), 1-6, 12.2020
- Creator
-
Alothman, Maram
Althobaity, Waleed
Asiri, Yasser
Alreshoodi, Saleh
Alismail, Khalid
Alshaalan, Meshal
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13244-020-00845-y
- URN
-
urn:nbn:de:101:1-2020052207255330788383
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alothman, Maram
- Althobaity, Waleed
- Asiri, Yasser
- Alreshoodi, Saleh
- Alismail, Khalid
- Alshaalan, Meshal
- SpringerLink (Online service)
Other Objects (12)
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Giant Proliferating Trichilemmal Tumor
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Radiologic and clinical changes after denosumab treatment for giant cell tumors of the mobile spine: a quantitative study
Correlating the treatment outcome with tumor staging, grading, and various treatment modalities in patients with esthesioneuroblastoma
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius
Innovative therapy modalities for solid EpCAM-positive tumors
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Giant Proliferating Trichilemmal Tumor
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Radiologic and clinical changes after denosumab treatment for giant cell tumors of the mobile spine: a quantitative study
Correlating the treatment outcome with tumor staging, grading, and various treatment modalities in patients with esthesioneuroblastoma
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius
Innovative therapy modalities for solid EpCAM-positive tumors
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Giant Proliferating Trichilemmal Tumor
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Radiologic and clinical changes after denosumab treatment for giant cell tumors of the mobile spine: a quantitative study
Correlating the treatment outcome with tumor staging, grading, and various treatment modalities in patients with esthesioneuroblastoma
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius